BeOne Medicines wins FDA Priority Review for BRUKINSA combination in first-line mantle cell lymphoma
Sectra wins seven-year radiology reporting contract with Mount Sinai Health System
Pentixapharm advances preparationsfor Phase 3 PANDA study
ABIONYX Pharma partners with Lille University Hospital to explore CER-001 for severe burn patients
Samsung Biologics awarded 'Negligible Risk' rating in Sustainalytics ESG assessment
CStone and Kimia Therapeutics collaborate to advance oncology drug candidate
Moberg Pharma secures US patent for MOB-015 dosing regimen
Merck launches Phase 3 trial of Ohtuvayre for COPD exacerbation prevention
Vivesto secures US orphan drug designation for Cantrixil in acute myeloid leukemia
Lytix Biopharma's ruxotemitide combination meets primary endpoint in Phase II melanoma trial